Ambrx Biopharma Inc (DELISTED) (AMAM:DL)
27.99
+0.01
(+0.04%)
USD |
NASDAQ |
Mar 06, 16:00
Ambrx Biopharma Revenue (Annual): 7.402M for Dec. 31, 2022
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2022 | 7.402M |
December 31, 2021 | 7.455M |
Date | Value |
---|---|
December 31, 2020 | 13.67M |
December 31, 2019 | 10.31M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
7.402M
Minimum
2022
13.67M
Maximum
2020
9.710M
Average
8.883M
Median
Revenue (Annual) Benchmarks
Johnson & Johnson | 85.16B |
Axonics Inc | 366.38M |
Harpoon Therapeutics Inc (DELISTED) | 31.92M |
Merck & Co Inc | 60.12B |
RayzeBio inc (DELISTED) | -- |